Aclaris Therapeutics, Inc. (8AT)
Market Open
12 Jun, 06:03
XFRA 
€
3. 74
+0.21
+6.0623%
€
- Market Cap
- P/E Ratio
- Div Yield
500 Volume
-1.64 Eps
€ 3.53
Previous Close Want to track 8AT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
8AT Earnings Reports FAQ
What is the earnings per share (EPS) for 8AT?
The current EPS is -1.64.
What is the company's earnings growth rate?
Aclaris Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Aclaris Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Aclaris Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 8AT at this time, as Aclaris Therapeutics, Inc has no recent EPS data to calculate it.
